Form 4: HilleVax CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
HilleVax CEO Robert Hershberg sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- Robert Hershberg, CEO of HilleVax, Inc., sold 14,634 shares of common stock on February 4, 2025, at a price of $1.89 per share.
- He then sold 11,901 shares of common stock on February 11, 2025, at a weighted average price of $1.7648 per share.
- These sales were mandated by HilleVax to cover tax withholding obligations upon the settlement of restricted stock units (RSUs).
- Following these transactions, Hershberg directly owns 1,101,498 shares of HilleVax common stock.
Sentiment
Score: 5
Explanation: The document reflects routine transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Sales of shares to cover tax obligations upon RSU settlement are a common practice among company executives.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Sale of 14,634 shares of common stock at $1.89 per share. |
| 02/11/2025 | Sale of 11,901 shares of common stock at a weighted average price of $1.7648 per share. |
| 02/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.